Helping you make wiser investment decisions

Latest Stories

Takeda keeps divestment spree rolling with $1.2B sale of diabetes meds to Japanese firm Teijin

After inking a slate of geography-specific product selloffs last year, Takeda has turned back to Japan. Takeda locked up a deal to sell four Type 2 diabetes meds in Japan to local drugmaker Teijin Pharma for 133 billion Japanese yen ($1.2 billion), freeing up the company to focus on its core businesses in gastroenterology, rare […]

Middleby’s 4Q Profit, Sales Top Analysts’ Estimates; Shares Surge 7%

Middleby Corp. reported stronger-than-expected 4Q performance as demand for indoor dining is on the rise and commercial foodservice orders improved. Shares of the kitchen and food service equipment maker spiked about 7% Monday’s morning trading session. Driven by 60% growth in Middleby’s commercial food service segment and 270% growth in its residential kitchen segment, its […]

Perrigo’s generics split is back on the docket, thanks to $1.55B Altaris offer

Perrigo pumped the brakes on its prescription generics hive-off last year, but, now, it has a buyer locked in and expects the split to go through by summer’s end. Perrigo clinched a deal to sell its prescription generics business to Altaris Capital Partners for $1.55 million—a price analysts deemed “pretty good” under the circumstances. Once […]

General

Middleby’s 4Q Profit, Sales Top Analysts’ Estimates; Shares Surge 7%

Middleby Corp. reported stronger-than-expected 4Q performance as demand for indoor dining is on the rise and commercial foodservice orders improved. Shares of the kitchen and food service equipment maker spiked about 7% Monday’s morning trading session. Driven by 60% growth in Middleby’s commercial food service segment and 270% growth in its residential kitchen segment, its […]

How Long Does Competitive Advantage Last? A Sector Analysis

Economic theory holds that absent monopoly powers and barriers to entry, every firm’s competitive advantage in an industry will diminish and its profits fall to zero over time. While this is just economic theory, it raises some interesting questions: Does a firm’s competitive advantage tend to endure longer in some sectors than others? And if […]

Aswath Damodaran on the COVID Crucible: A Play in Three Acts

Aswath Damodaran determined early on not to treat the COVID-19 crisis like previous market shocks. As the pandemic unfolded, he could see how it was developing and realized it was having the same three-stage effect on investors as previous financial upheavals. “First you lose perspective. Why? Because in the middle of chaos, things are melting […]

Making sense of the markets this week: March 1, 2021

Powell soothed the markets, suggesting he doesn’t see the threat of inflation—ha! The commodities and bond markets would disagree.  From that same Business Insider post…  “‘So soothing words for markets seems likely but the inflation fears are unlikely to go away whatever he says,’ Deutsche Bank strategist Jim Reid said.”   And here is a great […]

Pharmaceuticals, health and wellness

Takeda keeps divestment spree rolling with $1.2B sale of diabetes meds to Japanese firm Teijin

After inking a slate of geography-specific product selloffs last year, Takeda has turned back to Japan. Takeda locked up a deal to sell four Type 2 diabetes meds in Japan to local drugmaker Teijin Pharma for 133 billion Japanese yen ($1.2 billion), freeing up the company to focus on its core businesses in gastroenterology, rare […]

Perrigo’s generics split is back on the docket, thanks to $1.55B Altaris offer

Perrigo pumped the brakes on its prescription generics hive-off last year, but, now, it has a buyer locked in and expects the split to go through by summer’s end. Perrigo clinched a deal to sell its prescription generics business to Altaris Capital Partners for $1.55 million—a price analysts deemed “pretty good” under the circumstances. Once […]

Johnson & Johnson’s COVID vaccine scores FDA panel backing, setting up likely authorization

A month after Johnson & Johnson’s COVID-19 vaccine posted positive data in a phase 3 study, the shot is almost ready for prime time. Late Friday, a key panel unanimously endorsed the vaccine for emergency use and sent it to the agency for an official decision. An FDA authorization for the one-dose vaccine would provide a quick lift […]

Vials maker Stevanto plans IPO as coronavirus vaccine companies clamor for packaging: Reuters

The global pandemic promised a windfall for forward-thinking companies making products to help combat the spread of the coronavirus. Count the Stevanto Group, one of the world’s foremost makers of glass vials, among them. Since the onset of the pandemic, business has been booming at the 72-year-old Italian company, so much so that Stevanto is […]

Blockchain

Libra Co-Creator’s VC Firm Co-Leads $12M Round in ‘Decentralized GitHub’

In retrospect, it was inevitable: A team of blockchain developers has forked GitHub and come up with a system for collaborating on open source software. There’s even a decentralized finance (DeFi) twist. Announced Thursday, Radicle, a fully decentralized code repository, has raised $12 million in funding, integrated its peer-to-peer network with Ethereum and launched the […]

Coinbase Hires Former Stripe Exec as Chief Compliance Officer

Cryptocurrency exchange Coinbase has hired a former executive of payments company Stripe to head its compliance efforts. Melissa Strait joins the San-Francisco-based exchange as chief compliance officer where she will be charged with ensuring company accountability, transparency and customer financial safety, Coinbase announced Wednesday. Strait brings a wealth of experience at Stripe, having served more […]

Will 2021 Finally Be the Year of the Bitcoin ETF?

There’s been renewed interest in bitcoin exchange-traded funds (ETFs) with the nomination of Gary Gensler to head the Securities and Exchange Commission and the approval of a true Canadian bitcoin ETF. Whether one gets approved in the U.S. is still unclear. You’re reading State of Crypto, a CoinDesk newsletter looking at the intersection of cryptocurrency […]

New Emerging Markets Fund Targets Blockchain Startups

Asset management firms Alpha Innovations and Arcanum Capital have launched a $10 million venture capital fund focused on driving blockchain innovation in emerging markets.   The Arcanum Emerging Technologies Fund is to be the first of a series, with an initial close expected in late February, according to a company statement. The fund will provide seed […]

A directory listing for active private placement offerings

Greenway

Raising $5,000,000

Led by the team from DelFresco Pure, this cannabis company boasts an illustrious track-record of growing and distributing. Check out the pre-IPO opportunity before Greenway goes public.

Terms

$0.50 per share

Frontier Wellness Management

Frontier Wellness Management is raising funds to finance an expansion into Spain’s watershed cannabinoid market. Investors now have the opportunity to purchase stock in Frontier Wellness Management before it’s listed on a public exchange.

Prime Meridian Resources

PMR is a resource mining company operating in Minnesota and Michigan. They became publicly traded in April, 2019, and are building value through rapid development.